144 related articles for article (PubMed ID: 1419619)
1. Clinical pharmacokinetics of epirubicin: the importance of liver biochemistry tests.
Twelves CJ; Dobbs NA; Michael Y; Summers LA; Gregory W; Harper PG; Rubens RD; Richards MA
Br J Cancer; 1992 Oct; 66(4):765-9. PubMed ID: 1419619
[TBL] [Abstract][Full Text] [Related]
2. Epirubicin in hepatocellular carcinoma: pharmacokinetics and clinical activity.
Dobbs NA; Twelves CJ; Rizzi P; Warwick JD; Metivier EM; Williams R; Johnson PJ
Cancer Chemother Pharmacol; 1994; 34(5):405-10. PubMed ID: 8070007
[TBL] [Abstract][Full Text] [Related]
3. Epirubicin in breast cancer patients with liver metastases and abnormal liver biochemistry: initial weekly treatment followed by rescheduling and intensification.
Twelves CJ; Richards MA; Smith P; Rubens RD
Ann Oncol; 1991 Oct; 2(9):663-6. PubMed ID: 1742222
[TBL] [Abstract][Full Text] [Related]
4. Epirubicin in patients with liver dysfunction: development and evaluation of a novel dose modification scheme.
Dobbs NA; Twelves CJ; Gregory W; Cruickshanka C; Richards MA; Rubens RD
Eur J Cancer; 2003 Mar; 39(5):580-6. PubMed ID: 12628836
[TBL] [Abstract][Full Text] [Related]
5. A population model of epirubicin pharmacokinetics and application to dosage guidelines.
Ralph LD; Thomson AH; Dobbs NA; Twelves C
Cancer Chemother Pharmacol; 2003 Jul; 52(1):34-40. PubMed ID: 12764671
[TBL] [Abstract][Full Text] [Related]
6. Weekly epirubicin for breast cancer with liver metastases and abnormal liver biochemistry.
Twelves CJ; O'Reilly SM; Coleman RE; Richards MA; Rubens RD
Br J Cancer; 1989 Dec; 60(6):938-41. PubMed ID: 2605102
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin pharmacokinetics: the effect of abnormal liver biochemistry tests.
Twelves CJ; Dobbs NA; Gillies HC; James CA; Rubens RD; Harper PG
Cancer Chemother Pharmacol; 1998; 42(3):229-34. PubMed ID: 9685058
[TBL] [Abstract][Full Text] [Related]
8. Gender affects doxorubicin pharmacokinetics in patients with normal liver biochemistry.
Dobbs NA; Twelves CJ; Gillies H; James CA; Harper PG; Rubens RD
Cancer Chemother Pharmacol; 1995; 36(6):473-6. PubMed ID: 7554038
[TBL] [Abstract][Full Text] [Related]
9. Does breast feeding influence liver biochemistry?
Jørgensen MH; Ott P; Juul A; Skakkebaek NE; Michaelsen KF
J Pediatr Gastroenterol Nutr; 2003 Nov; 37(5):559-65. PubMed ID: 14581797
[TBL] [Abstract][Full Text] [Related]
10. Liver metastases from breast cancer: the relationship between clinical, biochemical and pathological features and survival.
O'Reilly SM; Richards MA; Rubens RD
Eur J Cancer; 1990; 26(5):574-7. PubMed ID: 2144744
[TBL] [Abstract][Full Text] [Related]
11. Are elevated liver enzymes and bilirubin levels significant after laparoscopic cholecystectomy in the absence of bile duct injury?
Halevy A; Gold-Deutch R; Negri M; Lin G; Shlamkovich N; Evans S; Cotariu D; Scapa E; Bahar M; Sackier JM
Ann Surg; 1994 Apr; 219(4):362-4. PubMed ID: 8161261
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting epirubicin pharmacokinetics and toxicity: evidence against using body-surface area for dose calculation.
Gurney HP; Ackland S; Gebski V; Farrell G
J Clin Oncol; 1998 Jul; 16(7):2299-304. PubMed ID: 9667243
[TBL] [Abstract][Full Text] [Related]
13. The liver profile in patients with hepatitis C virus and/or fascioliasis.
Wahib AA; el-Nasr MS; Mangoud AM; el-Shazly AM; Morsy AT
J Egypt Soc Parasitol; 2006 Aug; 36(2):405-40. PubMed ID: 16927859
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of non-invasive indices for liver histology in patients with chronic hepatitis B].
Chen YP; Zhu YF; Feng XR; Peng J; Hou JL
Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1181-3. PubMed ID: 15485795
[TBL] [Abstract][Full Text] [Related]
15. The value of liver function tests in hepatocellular carcinoma.
Lopez JB; Balasegaram M; Thambyrajah V; Timor J
Malays J Pathol; 1996 Dec; 18(2):95-9. PubMed ID: 10879229
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of oral etoposide in patients with hepatocellular carcinoma.
Aita P; Robieux I; Sorio R; Tumolo S; Corona G; Cannizzaro R; Colussi AM; Boiocchi M; Toffoli G
Cancer Chemother Pharmacol; 1999; 43(4):287-94. PubMed ID: 10071979
[TBL] [Abstract][Full Text] [Related]
17. Incidence and methodologic aspects of the occurrence of liver metastases in recurrent breast cancer.
Kamby C; Dirksen H; Vejborg I; Daugaard S; Guldhammer B; Rossing N; Mouridsen HT
Cancer; 1987 Apr; 59(8):1524-9. PubMed ID: 3545442
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with non-metastatic breast cancer.
Liu X; Meng QH; Ye Y; Hildebrandt MA; Gu J; Wu X
Carcinogenesis; 2015 Feb; 36(2):243-8. PubMed ID: 25524924
[TBL] [Abstract][Full Text] [Related]
19. Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF.
Samsky MD; Dunning A; DeVore AD; Schulte PJ; Starling RC; Tang WH; Armstrong PW; Ezekowitz JA; Butler J; McMurray JJ; Teerlink JR; Voors AA; Metra M; Mentz RJ; O'Connor CM; Patel CB; Hernandez AF
Eur J Heart Fail; 2016 Apr; 18(4):424-32. PubMed ID: 26707029
[TBL] [Abstract][Full Text] [Related]
20. Correlation of liver biochemistry with liver stiffness in chronic hepatitis B and development of a predictive model for liver fibrosis.
Fung J; Lai CL; Fong DY; Yuen JC; Wong DK; Yuen MF
Liver Int; 2008 Dec; 28(10):1408-16. PubMed ID: 18482268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
